Deal With South Korean Firm Brings Jobs To Vt.
Deal with South Korean firm brings promise of jobs to Vt.'s Orleans County
04:00PM 10/23/09
Deal With South Korean Firm Brings Jobs To Vermont
Deal with South Korean firm brings promise of jobs to Vermont's Orleans County
03:37PM 10/23/09
Maintaining a Patient Strategy (Biotech Select $)
The long-term thesis on this name, which smartly rejected an undervalued takeover offer last week, remains intact.
10:11AM 02/23/09
Making an Exit (Biotech Select $)
Closing out one disappointing long position, contemplating the merits of adding a new name and updating a short pick.
10:22AM 02/18/09
Signs of Life Returning to Biotech Sector (Biotech Select $)
The overall strength is reflected in the model portfolio, as more than half of the long positions are now in the green.
09:47AM 02/09/09
For Myriad Genetics, the Splice Is Right
Myriad Genetics shares were soaring Tuesday after the firm announced a healthy second quarter that beat analyst expectations.
01:10PM 02/03/09
Takeover Offer Gets Hostile (Biotech Select $)
This model portfolio name is likely to rebuff Roche's new bid. Also, news on some other model portfolio names.
12:59PM 02/02/09
A New Short Play (Biotech Select $)
Adding this stem-cell name to the model portfolio as its spotty track record and inflated market cap make it ripe for a fall.
09:27AM 01/26/09
Biotech Stock Mailbag: Panacos
Panacos is worth more than 12 cents -- and is worth hanging on to.
06:59AM 01/23/09
A Disappointing Deal (Biotech Select $)
This recent addition to the model portfolio found a buyer for its HIV program, but the terms are less than ideal.
10:33AM 01/21/09
Searching for New Names (Biotech Select $)
The health care conference in California going on now should provide some new ideas for the model portfolio.
09:11AM 01/12/09
Fundamentals Are Solid (Biotech Select $)
Despite a rough year, the model portfolio produced a few true winners in 2008, and quality picks remain in place.
10:03AM 01/05/09
New Year, New Model Portfolio Addition (Biotech Select $)
Establishing a position in this beaten-down stock, as there is potential to be found in one of its experimental drugs.
07:55AM 12/31/08
Biotech Mailbag: Savient's Unpleasant Surprise
Savient Pharmaceuticals on Monday released new safety data linking its gout drug Puricase to serious cardiovascular side effects.
03:19PM 10/31/08
Biotech Mailbag: Savient's Unpleasant Surprise (RealMoney.com $)
Savient Pharmaceuticals on Monday released new safety data linking its gout drug Puricase to serious cardiovascular side effects.
07:10AM 10/31/08
Connect with TheStreet